{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:17:45Z","timestamp":1793038665148,"version":"4.5.0"},"reference-count":34,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Programs of NEI\/NIH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Proinflammatory T-lymphocytes recruited into the brain and spinal cord mediate multiple sclerosis (MS) and currently there is no cure for MS. IFN-\u03b3-producing Th1 cells induce ascending paralysis in the spinal cord while IL-17-producing Th17 cells mediate cerebellar ataxia. STAT1 and STAT3 are required for Th1 and Th17 development, respectively, and the simultaneous targeting of STAT1 and STAT3 pathways is therefore a potential therapeutic strategy for suppressing disease in the spinal cord and brain. However, the pharmacological targeting of STAT1 and STAT3 presents significant challenges because of their intracellular localization. We have developed a STAT-specific single-domain nanobody (SBT-100) derived from camelids that targets conserved residues in Src homolog 2 (SH2) domains of STAT1 and STAT3. This study investigated whether SBT-100 could suppress experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We show that SBT-100 ameliorates encephalomyelitis through suppressing the expansion of Th17 and Th1 cells in the brain and spinal cord. Adoptive transfer experiments revealed that lymphocytes from SBT-100-treated EAE mice have reduced capacity to induce EAE, indicating that the immunosuppressive effects derived from the direct suppression of encephalitogenic T-cells. The small size of SBT-100 makes this STAT-specific nanobody a promising immunotherapy for CNS autoimmune diseases, including multiple sclerosis.<\/jats:p>","DOI":"10.3390\/cells13121042","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T04:48:12Z","timestamp":1718599692000},"page":"1042","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2636-3769","authenticated-orcid":false,"given":"Evaristus C.","family":"Mbanefo","sequence":"first","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3545-0489","authenticated-orcid":false,"given":"Allison","family":"Seifert","sequence":"additional","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8603-6148","authenticated-orcid":false,"given":"Manoj Kumar","family":"Yadav","sequence":"additional","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-0362","authenticated-orcid":false,"given":"Cheng-Rong","family":"Yu","sequence":"additional","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-7172","authenticated-orcid":false,"given":"Vijayaraj","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4392-1067","authenticated-orcid":false,"given":"Ashutosh","family":"Parihar","sequence":"additional","affiliation":[{"name":"Singh Biotechnology, 1547 Fox Grape Loop, Lutz, FL 33558, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Singh","sequence":"additional","affiliation":[{"name":"Singh Biotechnology, 1547 Fox Grape Loop, Lutz, FL 33558, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Egwuagu","sequence":"additional","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Immunology, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: Transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e24134","DOI":"10.4161\/jkst.24134","article-title":"Therapeutic targeting of STAT pathways in CNS autoimmune diseases","volume":"2","author":"Egwuagu","year":"2013","journal-title":"JAK-STAT"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2009.07.003","article-title":"STAT3 in CD4+ T helper cell differentiation and inflammatory diseases","volume":"47","author":"Egwuagu","year":"2009","journal-title":"Cytokine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molcel.2005.02.021","article-title":"Structural bases of unphosphorylated STAT1 association and receptor binding","volume":"17","author":"Mao","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1111\/j.1432-1033.2004.04423.x","article-title":"Nucleocytoplasmic shuttling of STAT transcription factors","volume":"271","author":"Meyer","year":"2004","journal-title":"Eur. J. Biochem. FEBS"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/brain\/119.3.709","article-title":"Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI","volume":"119","author":"Thorpe","year":"1996","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.sc.3101798","article-title":"Clinical characteristics, course and prognosis of spinal multiple sclerosis","volume":"43","author":"Nociti","year":"2005","journal-title":"Spinal Cord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1084\/jem.20080155","article-title":"Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis","volume":"205","author":"Lees","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-018-1237-y","article-title":"An IFNgamma\/CXCL2 regulatory pathway determines lesion localization during EAE","volume":"15","author":"Stoolman","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4049\/jimmunol.1400825","article-title":"Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis","volume":"193","author":"Stoolman","year":"2014","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2012.01126.x","article-title":"Mechanisms regulating regional localization of inflammation during CNS autoimmunity","volume":"248","author":"Pierson","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"724609","DOI":"10.3389\/fimmu.2021.724609","article-title":"STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice","volume":"12","author":"Mbanefo","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1178223417750858","DOI":"10.1177\/1178223417750858","article-title":"Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3","volume":"12","author":"Singh","year":"2018","journal-title":"Breast Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.178.4.2589","article-title":"IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis","volume":"178","author":"Thakker","year":"2007","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nprot.2009.2","article-title":"Protein structure prediction on the Web: A case study using the Phyre server","volume":"4","author":"Kelley","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: A web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"ref_20","unstructured":"Schr\u00f6dinger, L., and DeLano, W. (2023, December 10). PyMOL. Volume 2020. Available online: http:\/\/www.pymol.org\/pymol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30436","DOI":"10.1074\/jbc.M112.359661","article-title":"STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear\/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells","volume":"287","author":"Oh","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"30888","DOI":"10.1074\/jbc.M111.253500","article-title":"STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O Forkhead transcription factors","volume":"286","author":"Oh","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.4049\/jimmunol.161.9.4652","article-title":"Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice","volume":"161","author":"Takeda","year":"1998","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20020509","article-title":"Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: Increased susceptibility to autoimmune disease","volume":"199","author":"Nishibori","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.4049\/jimmunol.180.9.6070","article-title":"Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases","volume":"180","author":"Liu","year":"2008","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4049\/jimmunol.145.2.576","article-title":"Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors","volume":"145","author":"Griffin","year":"1990","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"Ciric","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.20091844","article-title":"GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization","volume":"207","author":"King","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"650708","DOI":"10.3389\/fimmu.2021.650708","article-title":"Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase\/Signal Transducer and Activator of Transcription Signaling Pathway","volume":"12","author":"Dang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4049\/jimmunol.1301513","article-title":"Therapeutic efficacy of suppressing the Jak\/STAT pathway in multiple models of experimental autoimmune encephalomyelitis","volume":"192","author":"Liu","year":"2014","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.msard.2020.102568","article-title":"CNS demyelination during tofacitinib therapy: First report","volume":"46","author":"Massoud","year":"2020","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/12\/1042\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:38Z","timestamp":1760108378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/12\/1042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["cells13121042"],"URL":"https:\/\/doi.org\/10.3390\/cells13121042","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,16]]}}}